|
[Related PubMed/MEDLINE] Total Number of Papers: 7
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2020 |
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. |
COVID-19, SARS-CoV-2 |
2 |
2018 |
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). |
Env, MVA |
3 |
2015 |
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans. |
Env, HIV-1 |
4 |
2015 |
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys. |
Env |
5 |
2013 |
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). |
Ad26.ENVA.01, HIV-1, IPCAVD |
6 |
2012 |
Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys. |
--- |
7 |
2011 |
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge. |
Ad, Ad5, EBOV, GP |
|